BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 26554887)

  • 1. Interferon regulatory factor 8 and the regulation of neutrophil, monocyte, and dendritic cell production.
    Yáñez A; Goodridge HS
    Curr Opin Hematol; 2016 Jan; 23(1):11-7. PubMed ID: 26554887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IRF8 acts in lineage-committed rather than oligopotent progenitors to control neutrophil vs monocyte production.
    Yáñez A; Ng MY; Hassanzadeh-Kiabi N; Goodridge HS
    Blood; 2015 Feb; 125(9):1452-9. PubMed ID: 25597637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of myelopoiesis by the transcription factor IRF8.
    Tamura T; Kurotaki D; Koizumi S
    Int J Hematol; 2015 Apr; 101(4):342-51. PubMed ID: 25749660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional and Epigenetic Regulation of Innate Immune Cell Development by the Transcription Factor, Interferon Regulatory Factor-8.
    Kurotaki D; Tamura T
    J Interferon Cytokine Res; 2016 Jul; 36(7):433-41. PubMed ID: 27379865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation.
    Kurotaki D; Osato N; Nishiyama A; Yamamoto M; Ban T; Sato H; Nakabayashi J; Umehara M; Miyake N; Matsumoto N; Nakazawa M; Ozato K; Tamura T
    Blood; 2013 Mar; 121(10):1839-49. PubMed ID: 23319570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Regulation of mononuclear phagocyte development by IRF8].
    Tamura T
    Rinsho Ketsueki; 2017; 58(7):798-805. PubMed ID: 28781277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.
    Paschall AV; Zhang R; Qi CF; Bardhan K; Peng L; Lu G; Yang J; Merad M; McGaha T; Zhou G; Mellor A; Abrams SI; Morse HC; Ozato K; Xiong H; Liu K
    J Immunol; 2015 Mar; 194(5):2369-79. PubMed ID: 25646302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Granulocyte Progenitor Stage Is a Key Target of IRF8-Mediated Regulation of Myeloid-Derived Suppressor Cell Production.
    Netherby CS; Messmer MN; Burkard-Mandel L; Colligan S; Miller A; Cortes Gomez E; Wang J; Nemeth MJ; Abrams SI
    J Immunol; 2017 May; 198(10):4129-4139. PubMed ID: 28356386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic control of early dendritic cell lineage specification by the transcription factor IRF8 in mice.
    Kurotaki D; Kawase W; Sasaki H; Nakabayashi J; Nishiyama A; Morse HC; Ozato K; Suzuki Y; Tamura T
    Blood; 2019 Apr; 133(17):1803-1813. PubMed ID: 30796024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PU.1 level-directed chromatin structure remodeling at the Irf8 gene drives dendritic cell commitment.
    Schönheit J; Kuhl C; Gebhardt ML; Klett FF; Riemke P; Scheller M; Huang G; Naumann R; Leutz A; Stocking C; Priller J; Andrade-Navarro MA; Rosenbauer F
    Cell Rep; 2013 May; 3(5):1617-28. PubMed ID: 23623495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IRF8 inhibits C/EBPα activity to restrain mononuclear phagocyte progenitors from differentiating into neutrophils.
    Kurotaki D; Yamamoto M; Nishiyama A; Uno K; Ban T; Ichino M; Sasaki H; Matsunaga S; Yoshinari M; Ryo A; Nakazawa M; Ozato K; Tamura T
    Nat Commun; 2014 Sep; 5():4978. PubMed ID: 25236377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irf8 regulates macrophage versus neutrophil fate during zebrafish primitive myelopoiesis.
    Li L; Jin H; Xu J; Shi Y; Wen Z
    Blood; 2011 Jan; 117(4):1359-69. PubMed ID: 21079149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Third Intron of IRF8 Is a Cell-Type-Specific Chromatin Priming Element during Mouse Embryonal Stem Cell Differentiation.
    Khateb M; Azriel A; Levi BZ
    J Mol Biol; 2019 Jan; 431(2):210-222. PubMed ID: 30502383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively.
    Sichien D; Scott CL; Martens L; Vanderkerken M; Van Gassen S; Plantinga M; Joeris T; De Prijck S; Vanhoutte L; Vanheerswynghels M; Van Isterdael G; Toussaint W; Madeira FB; Vergote K; Agace WW; Clausen BE; Hammad H; Dalod M; Saeys Y; Lambrecht BN; Guilliams M
    Immunity; 2016 Sep; 45(3):626-640. PubMed ID: 27637148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modelling IRF8 Deficient Human Hematopoiesis and Dendritic Cell Development with Engineered iPS Cells.
    Sontag S; Förster M; Qin J; Wanek P; Mitzka S; Schüler HM; Koschmieder S; Rose-John S; Seré K; Zenke M
    Stem Cells; 2017 Apr; 35(4):898-908. PubMed ID: 28090699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Batf3 and Id2 have a synergistic effect on Irf8-directed classical CD8α+ dendritic cell development.
    Jaiswal H; Kaushik M; Sougrat R; Gupta M; Dey A; Verma R; Ozato K; Tailor P
    J Immunol; 2013 Dec; 191(12):5993-6001. PubMed ID: 24227775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
    Durai V; Bagadia P; Granja JM; Satpathy AT; Kulkarni DH; Davidson JT; Wu R; Patel SJ; Iwata A; Liu TT; Huang X; Briseño CG; Grajales-Reyes GE; Wöhner M; Tagoh H; Kee BL; Newberry RD; Busslinger M; Chang HY; Murphy TL; Murphy KM
    Nat Immunol; 2019 Sep; 20(9):1161-1173. PubMed ID: 31406378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors.
    Becker AM; Michael DG; Satpathy AT; Sciammas R; Singh H; Bhattacharya D
    Blood; 2012 Mar; 119(9):2003-12. PubMed ID: 22238324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional control of dendritic cell development.
    Murphy KM
    Adv Immunol; 2013; 120():239-67. PubMed ID: 24070387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The transcription factor IRF8 counteracts BCR-ABL to rescue dendritic cell development in chronic myelogenous leukemia.
    Watanabe T; Hotta C; Koizumi S; Miyashita K; Nakabayashi J; Kurotaki D; Sato GR; Yamamoto M; Nakazawa M; Fujita H; Sakai R; Fujisawa S; Nishiyama A; Ikezawa Z; Aihara M; Ishigatsubo Y; Tamura T
    Cancer Res; 2013 Nov; 73(22):6642-53. PubMed ID: 24242069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.